Cutler Group LP Bellus Health Inc. Call Options Transaction History

Cutler Group LP

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 04, 2022	SELL	$6.46 - $10.02 $21,964 - $34,068	-3,400 Reduced 97.14%	100 $0
Q1 2022 Apr 14, 2022	SELL	$5.56 - $7.99 $285,784 - $410,686	-51,400 Reduced 93.62%	3,500 $1,000
Q4 2021 Jan 18, 2022	BUY	$5.26 - $8.3 $253,532 - $400,060	48,200 Added 719.4%	54,900 $40,000
Q3 2021 Oct 26, 2021	BUY	$2.7 - $6.64 $18,090 - $44,488	6,700 New	6,700 $2,000

128K

Ticker BLU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 125,793,000
Description
BELLUS Health Inc., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of refractory chronic cough (RCC) and other cough hypersensitivity indications. Its lead product candidate includes BLU-5937, an antagonist of the P2X3 receptor, which is in Phase II clinical trial for treatment of RCC and chronic pruritus. Th...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.